Article
Radiology, Nuclear Medicine & Medical Imaging
Halil Komek, Canan Can, Ihsan Kaplan, Cihan Gundogan, Ferat Kepenek, Huseyin Karaoglan, Aykut Demirkiran, Senar Ebinc, Yunus Guzel, Ebubekir Gundes
Summary: [(68) Ga]Ga-DOTA-FAPI-04 PET/CT demonstrates higher sensitivity and specificity in the evaluation of primary lesions and metastases in patients with colorectal cancer.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Ihsan Kaplan, Canan Can, Yunus Guzel, Ulas Alabalik, Halil Komek
Summary: F-18-FDG PET/CT and Ga-68-FAPI 04 PET/CT were used for restaging in a 16-year-old boy with malignant mixed germ cell tumor. Results showed that Ga-68-FAPI-04 PET/CT was superior to F-18-FDG PET/CT in the evaluation of metastases in the testicular tumor.
CLINICAL NUCLEAR MEDICINE
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Yaqun Jiang, Bing Wen, Chongjiao Li, Yueli Tian, Zhiwei Xiao, Kui Xu, Diankui Xing, Zili Yu, Jing Huang, Jun Jia, Yong He
Summary: This study compares the performance of Ga-68-FAPI-04 and F-18-FDG PET/CT in the staging and detection of recurrences in head and neck squamous cell carcinoma (HNSCC). The results showed that Ga-68-FAPI-04 PET/CT outperformed F-18-FDG PET/CT in evaluating preoperative N staging and detecting distant metastasis. It also showed potential in clinical management and monitoring treatment response.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Oncology
Huipan Liu, Zhi Hu, Xiao Yang, Tianyang Dai, Yue Chen
Summary: The study found that [Ga-68]Ga-DOTA-FAPI-04 PET/CT has better diagnostic performance in detecting primary and metastatic lesions of esophageal cancer compared to [F-18]FDG PET/CT. The technology showed higher accuracy in detecting lesions in treatment-naive patients and had higher sensitivity for primary tumors, lymph nodes, and bone and visceral metastases.
FRONTIERS IN ONCOLOGY
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Jie Ding, Jiangdong Qiu, Zhixin Hao, Hua Huang, Qiaofei Liu, Wenjing Liu, Chao Ren, Marcus Hacker, Taiping Zhang, Wenming Wu, Xiang Li, Li Huo
Summary: This study evaluated the performance of [(68) Ga]Ga-FAPI-04 and [F-18]F-FDG PET/CT on the disease staging and prognostic value of patients with localized PDAC. The results showed that [(68) Ga]Ga-FAPI-04 was more sensitive and accurate than [F-18]F-FDG, and could be used for staging and prognostic evaluation of PDAC, providing a non-invasive guide for clinical management.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xin Zhou, Shuailiang Wang, Xiaoxia Xu, Xiangxi Meng, Huiyuan Zhang, Annan Zhang, Yufei Song, Hua Zhu, Zhi Yang, Nan Li
Summary: This study compared the clinical staging performance of [(68) Ga]Ga-DOTA-FAPI-04 PET/CT and 2-[F-18]FDG PET/CT in non-small cell lung cancer (NSCLC) patients. The results showed that [(68) Ga]Ga-DOTA-FAPI-04 PET/CT had better staging performance in NSCLC patients, especially in localized disease.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Peipei Wang, Chen Li, Guozhu Hou, Zhaohui Li, Hongli Jing, Wen Zhang, Fang Li
Summary: The study demonstrates that PET/CT is useful in evaluating patients with SAPHO syndrome, a rare inflammatory disorder affecting bone, joints, and skin.
CLINICAL NUCLEAR MEDICINE
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Goksel Alcin, Esra Arslan, Tamer Aksoy, Merve Cin, Ozge Erol Fenercioglu, Ediz Beyhan, Nurhan Ergul, Tevfik Fikret Cermik
Summary: In this study, the PET findings of F-18-FDG PET/CT were compared with Ga-68-FAPI-04 PET/CT findings in breast cancer patients with low F-18-FDG uptake. The results showed that Ga-68-FAPI-04 PET/CT has higher sensitivity in detecting primary tumors and provides higher SUVmax values. Additionally, this method can contribute to increased detection of lymph node involvement and aid in patient management.
CLINICAL NUCLEAR MEDICINE
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Jie Chen, Kui Xu, Chongjiao Li, Yueli Tian, Ling Li, Bing Wen, Can He, Hongbing Cai, Yong He
Summary: [Ga-68]Ga-FAPI-04 PET/CT achieves higher sensitivity than [F-18]F-FDG PET/CT in the detection and diagnosis of lymph node and peritoneal metastases in epithelial ovarian cancer (EOC), suggesting advantages regarding the preoperative staging of patients with EOC and, thereby, improving treatment decision-making.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Jiayu Cai, Weizhi Xu, Tinghua Meng, YiZhen Pang, Haojun Chen
Summary: Mixed neuroendocrine carcinoma-acinar carcinoma is a rare type of neuroendocrine prostate cancer and has rarely been reported in de novo cases. In this case, we present the PET/CT findings of Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates the potential use of a multitracer PET/CT strategy for noninvasive detection of intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.
CLINICAL NUCLEAR MEDICINE
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xiang Li, Wenhui Ma, Min Wang, Zhiyong Quan, Mingru Zhang, Jiajun Ye, Guiyu Li, Xiang Zhou, Taoqi Ma, Junling Wang, Weidong Yang, Yongzhan Nie, Jing Wang, Fei Kang
Summary: This study compared the diagnostic efficacy of Ga-68-FAPI-04 PET and F-18-FDG PET for detecting anastomotic recurrence in postoperative patients with gastrointestinal cancer, and characterized the signal pattern over time at surgical wounds on both PET imaging. The results showed that Ga-68-FAPI-04 PET had higher sensitivity, specificity, positive and negative predictive values, and accuracy in detecting anastomotic recurrence compared to F-18-FDG PET. However, it was difficult to differentiate anastomotic recurrence from inflammation on either PET imaging.
MOLECULAR IMAGING AND BIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Bingxin Gu, Xin Liu, Shuoer Wang, Xiaoping Xu, Xiaosheng Liu, Silong Hu, Wangjun Yan, Zhiguo Luo, Shaoli Song
Summary: This study evaluated the diagnostic value of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT for recurrent soft tissue sarcoma (STS) and compared it with [F-18]FDG PET/CT. The results showed that [(68)Ga]Ga-DOTA-FAPI-04 PET/CT was more accurate than [F-18]FDG PET/CT in detecting recurrent lesions of liposarcoma, MSFT, and IDCS.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Haojun Chen, Liang Zhao, Dan Ruan, Yizhen Pang, Bing Hao, Yaqing Dai, Xiurong Wu, Wei Guo, Chunlei Fan, Jingxun Wu, Weipeng Huang, Qin Lin, Long Sun, Hua Wu
Summary: This prospective study evaluated the potential usefulness of [Ga-68]Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) in oncological evaluation of patients with inconclusive [F-18]FDG PET/CT findings. The study found that [Ga-68]Ga-DOTA-FAPI-04 may have a complementary role in discriminating mass lesions on conventional imaging, locating unknown primary sites in biopsy-proven metastatic malignancy, modifying tumor staging, and detecting suspected disease recurrence. However, caution should be exercised when interpreting [Ga-68]Ga-DOTA-FAPI-04 PET/CT images in tumors complicated with inflammation.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Rong Lin, Zefang Lin, Zhenying Chen, Shan Zheng, Jiaying Zhang, Jie Zang, Weibing Miao
Summary: This study compared the performance of [Ga-68]Ga-DOTA-FAPI-04 and [F-18]FDG PET/CT in evaluating gastric cancer. The results showed that [Ga-68]Ga-DOTA-FAPI-04 PET/CT outperformed [F-18]FDG PET/CT in detecting peritoneal, abdominal lymph node, and bone metastases. Additionally, [Ga-68]Ga-DOTA-FAPI-04 PET/CT provided more valuable information for patients with recurrent disease and had the potential in monitoring treatment response.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Ruohua Chen, Xinlan Yang, Xiaofeng Yu, Xiang Zhou, Yee Ling Ng, Yumei Chen, Lianghua Li, Yun Zhou, Gang Huang, Jianjun Liu
Summary: Ultra-early and fast imaging showed equivalent tumor detection and lesion uptake compared to traditional [(68) Ga]Ga-FAPI-04 imaging. This method could meet clinical diagnostic requirements for patients with intolerance to prolonged horizontal positioning and waiting time.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xiao Zhang, Wenyu Song, Chunxia Qin, Yangmeihui Song, Fang Liu, Fan Hu, Xiaoli Lan
Summary: Ga-68-FAPI-04 PET imaging is promising for cervical cancers, but physiological uptake may limit its diagnostic value in uterine body malignancy. Metastatic lesions in the uterus may have lower Ga-68-FAPI-04 uptake. Age, fibroids, and uterine volume can influence Ga-68-FAPI-04 uptake in the uterus. More patients with various uterine diseases could provide additional differential diagnostic information.
CLINICAL NUCLEAR MEDICINE
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xiao Zhang, Mengting Li, Yongkang Gai, Jing Chen, Juan Tao, Liu Yang, Fan Hu, Wenyu Song, Tzu-Chen Yen, Xiaoli Lan
Summary: 18F-PFPN is a novel PET probe with high affinity and selectivity for melanin, showing elevated radiochemical yield and stability in vivo. In clinical studies, it outperformed traditional 18F-FDG PET in identifying primary MM and its distant spread, demonstrating higher uptake and ability to detect more metastases. Additionally, it showed clinical value in distinguishing false-positive lesions on 18F-FDG PET.
JOURNAL OF NUCLEAR MEDICINE
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Wenyu Song, Xiao Zhang, ShuKun He, Yongkang Gai, Chunxia Qin, Fan Hu, Yan Wang, Zhaohui Wang, Peng Bai, Jing Wang, Xiaoli Lan
Summary: The feasibility of using Ga-68-FAPI PET/CT to visualize changes in cardiac fibrosis and function over time in heart failure (HF) was examined. The results of animal experiments and a clinical study in HF patients suggest that Ga-68-FAPI PET can be used to demonstrate active myocardial fibrosis and may assist in treatment decision making.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Xiao Zhang, Wenyu Song, Chunxia Qin, Xiaoli Lan
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Letter
Radiology, Nuclear Medicine & Medical Imaging
Yangmeihui Song, Qiaomiao Lu, Dawei Jiang, Xiaoli Lan
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Junlong Li, Xiao Zhang, Chunxia Qin, Xun Sun, Xiaojun Xu, Guoxiang Cao, Yongkang Gai, Chunyan Sun, Yu Hu, Xiaoli Lan
Summary: This study aimed to evaluate the prognosis of newly diagnosed multiple myeloma (NDMM) patients by combining [F-18]-FDG positron emission tomography (PET/CT) parameters and clinical indices. The study found that PET/CT parameters play a significant role in predicting prognosis in NDMM patients. The new prognostic prediction system (NPPS) based on SUVmax, sFLC ratio, and EMD showed better predictive effectiveness than the ISS, R-ISS, and R2-ISS.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Medicine, Research & Experimental
Yichun Wang, Mengting Li, Xiao Zhang, Hao Ji, Wenxia Wang, Na Han, Huiling Li, Xiaodong Xu, Xiaoli Lan
Summary: This study investigated the value of 18F-5-FPN in assessing the response to photothermal therapy in melanoma. The results showed that 18F-5-FPN PET can predict early response, recognize early recurrence, and distinguish inflammatory response during treatment. It provides a new approach for accurate evaluation of response, timely management of therapeutic regimens, and sensitive follow-up in melanoma.
MOLECULAR PHARMACEUTICS
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Margarita Kirienko, Giovanni Centonze, Giovanna Sabella, Mauro Sollai, Martina Sollini, Xiaoli Lan, Haojun Chen, Luigi Terracciano, Ettore Seregni, Massimo Milione
Summary: This study discovered the expression of FAP in alpha cells of the Langerhans islets in the pancreas, which has implications for the use of radioligands.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Qiaomiao Lu, Yu Long, Yongkang Gai, Qingyao Liu, Dawei Jiang, Xiaoli Lan
Summary: This study aimed to explore the feasibility of using [Lu-177]Lu-PSMA-617 and [Lu-177]Lu-EB-PSMA-617 for in vivo radioligand therapy in PSMA-positive hepatocellular carcinoma. The results showed that these radioligands significantly suppressed tumor growth and prolonged survival time without obvious toxicity, indicating their potential for clinical use in humans.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Weiwei Ruan, Chunxia Qin, Fang Liu, Rundong Pi, Yongkang Gai, Qingyao Liu, Xiaoli Lan
Summary: This study aimed to evaluate the potential of Q.Clear PET reconstruction in reducing tracer injection dose or scanning time in (68)Ga-FAPI PET/MR imaging. They collected retrospective cases of (68)Ga-FAPI whole-body imaging and compared three reconstruction methods: OSEM reconstruction with full scanning time, OSEM reconstruction with half scanning time, and Q.Clear reconstruction with half scanning time. The study found that Q.Clear reconstruction significantly increased SUVmax and SUVmean within lesions, reduced their volumes, and maintained image quality.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xiao Zhang, Zhaoguo Lin, Mengting Li, Yongkang Gai, Huaiyuan Zheng, Li Fan, Weiwei Ruan, Fan Hu, Jing Chen, Xiaoli Lan
Summary: This study aimed to investigate the value of [F-18]-PFPN PET in prognostication and determine predictors of PFS and OS in melanoma patients. The results showed that [F-18]-PFPN PET parameters were superior to [F-18]-FDG PET in predicting death and disease progression. Patients with higher [F-18]-PFPN SUVmax had worse prognosis.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Article
Oncology
Dawei Jiang, Xiaoli Lan, Weibo Cai
Summary: In a recent study, a new bicyclic peptide radiotracer, 68Ga-N188, was developed for PET imaging of advanced urothelial cancer. Preclinical investigation and first-in-human study showed excellent specificity and sensitivity of 68Ga-N188 in detecting metastases. These promising results support the use of 68Ga-N188 as a companion diagnostic for personalized cancer therapy.
CLINICAL CANCER RESEARCH
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Xiao Zhang, Fei Kang, Huaiyuan Zheng, Yongkang Gai, Jing Wang, Xiaoli Lan
Summary: This study investigates the feasibility of melanin-targeted [F-18]-PFPN PET in patients with clear cell sarcoma (CCS). The results demonstrate that this technique is effective in diagnosing CCS and complements other PET modalities.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Xiao Zhang, Mengyan Hu, Fei Kang, Jing Wang, Xiaoli Lan
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Review
Nanoscience & Nanotechnology
Mengting Li, Sheng Wang, Qunshou Kong, Xinyi Cheng, Huanhuan Yan, Yao Xing, Xiaoli Lan, Dawei Jiang
Summary: In recent years, radiometals have been widely used in medicine due to their diverse decay properties and increased production and availability. Bifunctional chelators are essential in radiometal-based radiopharmaceuticals, influencing the labeling, targeting, and pharmacokinetics of bioconjugations and ensuring the stable complexation of the metal in vivo. The exceptional thermodynamics, kinetics, and stability of macrocycles in forming complexes compared to acyclic chelators continue to attract the interest of pharmacists and biochemists. The discovery of novel ligand structures and modifications of chelators with suitable chemical and biological features is important for the development of new imaging modalities and therapeutic targets.